Zhen Su

Insider Reports History

Location
Newton, MA
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Zhen Su
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Zhen Su:

Company Role Class Num Shares Value Price $ Report Date Ownership
CytomX Therapeutics, Inc. Director Stock Option (Right to Buy) 38,000 11 Jun 2025 Direct
Karyopharm Therapeutics Inc. Director Nonstatutory Stock Option (right to buy) 4,600 28 May 2025 Direct

Insider Reports Filed by Zhen Su

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CTMX CytomX Therapeutics, Inc. 11 Jun 2025 1 $0 4 Director 13 Jun 2025, 16:19
KPTI Karyopharm Therapeutics Inc. 28 May 2025 1 $0 4 Director 29 May 2025, 16:15
KPTI Karyopharm Therapeutics Inc. 29 May 2024 1 $0 4 Director 30 May 2024, 17:32
CTMX CytomX Therapeutics, Inc. 15 May 2024 1 $0 4 Director 17 May 2024, 17:36
CTMX CytomX Therapeutics, Inc. 20 Mar 2024 1 $0 4 Director 22 Mar 2024, 16:27
CTMX CytomX Therapeutics, Inc. 20 Mar 2024 0 $0 3 Director 22 Mar 2024, 16:22
KPTI Karyopharm Therapeutics Inc. 31 Aug 2023 1 $0 4 Director 01 Sep 2023, 08:20
KPTI Karyopharm Therapeutics Inc. 31 Aug 2023 0 $0 3 Director 01 Sep 2023, 08:17